Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-16

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial compares the use of a new screening tool designed to evaluate patients' information needs, preferences, and illness understanding to the usual care to improve illness understanding in patients with lung cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or for which no curative treatment is currently available (incurable). Goal concordant care is a model of care that aligns a patient's medical care with their values, preferences, and goals. Often, patients may not fully understand their illness and prognosis, but this information is important so that they can make fully informed decisions regarding their care that are consistent with their values, preferences, and goals. Completing the Information Needs, Preferences, and Understanding Trial (INPUT) screening tool may allow for more frequent and regular discussions regarding disease status and treatment goals, ultimately resulting in improved patient illness understanding and goal concordant care for patients with metastatic or incurable lung cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Depression Screening in Patients With Lung Cancer

NCT00404365

Depression Lung Cancer

COMPLETED NA

Lung Cancer Screening: A Multilevel Intervention

NCT03862001

Lung Cancer

COMPLETED NA

Enhancing Lung Cancer Screening Through Human-Centered Intervention

NCT06351085

Lung Cancer

RECRUITING NA

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

NCT05679349

Lung Carcinoma Tobacco-Related Carcinoma

RECRUITING NA

Early Intervention Strategies for Lung Cancer

NCT06988943

Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site +4 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objectives To estimate the within group effect of perception of curability over 3 months in both the systematic screening group and the usual care group among patients with metastatic or incurable lung cancer who present to the thoracic medical oncology clinic at The University of Texas MD Anderson Cancer Center.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Carcinoma Metastatic Lung Carcinoma Stage IV Lung Cancer AJCC v8

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

The research staff conducting the outcomes assessment (other than acceptability) will be blinded to group assignment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I (Standard care)

Patients undergo standard of care oncology follow-up visits.

Group Type ACTIVE_COMPARATOR

Best Practice

Intervention Type OTHER

Other Best Practice best practice, standard of care, standard of care, standard of care, standard therapy Undergo standard of care oncology follow-up visits

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Arm II (INPUT screening)

Patients complete the INPUT screening tool at each of their standard of care follow up visits, with their medical oncology team.

Group Type EXPERIMENTAL

Best Practice

Intervention Type OTHER

Other Best Practice best practice, standard of care, standard of care, standard of care, standard therapy Undergo standard of care oncology follow-up visits

Questionnaire Administration

Intervention Type OTHER

Ancillary studies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Best Practice

Other Best Practice best practice, standard of care, standard of care, standard of care, standard therapy Undergo standard of care oncology follow-up visits

Intervention Type OTHER

Questionnaire Administration

Ancillary studies

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Within 3 months of biopsy-confirmed diagnosis of stage IV lung cancer
* Age 18 or over
* English speaking
* Attending a follow-up visit at the thoracic medical oncology clinic
* Plans to receive or actively undergoing cancer-directed systemic treatment at MD Anderson